Atomwise is comprised of a world-class team of diverse disciplines internally referred to as "Atoms." In this Atom Spotlight, we sit down for a Q&A session with Benjamin Samudio, PhD, a member of our Computer-Aided Drug Design (CADD) Scientist Team.
Long before SARS-CoV-2 triggered the worst pandemic most of us have ever experienced, Nito Panganiban was concerned about the ability of RNA viruses to leap from animal reservoirs into the human population. In the past century, there have been more […]
The Atomwise approach to drug discovery is based on the strong belief that virtual screening enabled by sophisticated AI-based computational models will accelerate the development of new drug candidates, and eventually achieve our mission of […]
Atomwise is a world-class team of diverse disciplines internally referred to as "Atoms." In this Atom Spotlight, Cornelius Corkery, a member of our Operations and People Teams, dives into Atomwise’s academic environment and talks about employee […]
While outcomes for breast cancer patients have steadily improved over the years, one particularly vexing type known as triple-negative breast cancer (TNBC) has continued to defy those rosy trends. One of the challenges in treating TNBC is that it […]
Here at Atomwise, we are really proud of the AtomNet® tool we’ve built to perform virtual screening of targets against billions of compounds to find promising candidates. This approach has already provided new leads for academic labs and drug […]
You probably hear about AI on a regular basis, but if you’re not a programmer steeped in machine learning algorithms, AI can seem like a mysterious black box.
Jeffrey MacKeigan is not your traditional academic scientist. After completing his postdoctoral fellowship, he spent two years at one of the largest pharmaceutical companies in the world. That gives him a unique perspective on how academic labs, […]
It’s not unusual for scientists to be discouraged by a lack of treatment options for their disease of interest. There is, however, a special kind of frustration for researchers who have clearly identified a promising biological target for treating […]